Systematic review demonstrates high rates of disability in inflammatory bowel disease, suggesting ongoing assessment is needed.
This systematic review is the first, to our knowledge, to show that moderate-to-severe disability affects nearly one-third of patients with IBD, with higher rates in Crohn disease and active disease. Importantly, disability persists in a substantial proportion of patients even during remission, supporting the need for systematic assessment across clinical settings.
No takes yet. Share an insight, caveat, or question.
Nardone et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: